Comprehensive molecular portraits of human breast tumours - Test2 - elhamkhani - TriplyDB

Comprehensive molecular portraits of human breast tumours

Comprehensive molecular portraits of human breast tumours

http://www.wikidata.org/entity/Q24630844

about

Identification of druggable cancer driver genes amplified across TCGA datasets Chapter 14: Cancer genome analysis Prolactin-induced protein (PIP) regulates proliferation of luminal A type breast cancer cells in an estrogen-independent manner Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases The landscape of long noncoding RNAs in the human transcriptome Cancer genome landscapes Transforming Epidemiology for 21st Century Medicine and Public Health KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer JARID1B is a luminal lineage-driving oncogene in breast cancer Phosphorylation of myofibrillogenesis regulator-1 activates the MAPK signaling pathway and induces proliferation and migration in human breast cancer MCF7 cells TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair MarvelD3 couples tight junctions to the MEKK1-JNK pathway to regulate cell behavior and survival Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling The Cancer Genome Atlas Pan-Cancer analysis project Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer Clinical Development of the CDK4/6 Inhibitors Ribociclib and Abemaciclib in Breast Cancer Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer CDK4/6 inhibition in luminal breast cancer The Role of Genomic Profiling in Advanced Breast Cancer: The Two Faces of Janus JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes Molecular profiles to biology and pathways: a systems biology approach A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to Tumorigenesis Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention Novel approaches to target HER2-positive breast cancer: trastuzumab emtansine Molecular biology of breast tumors and prognosis Aromatase expression and regulation in breast and endometrial cancer Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategies Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It Effects of the lifestyle habits in breast cancer transcriptional regulation Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers Strategies for Integrated Analysis of Genetic, Epigenetic, and Gene Expression Variation in Cancer: Addressing the Challenges The Role of Forkhead Box Protein M1 in Breast Cancer Progression and Resistance to Therapy PI3K/Akt/mTOR inhibitors in breast cancer

P2860

Q21090621-64CA8441-3DF0-483E-AFB8-4310DFA5D2EE Q21145309-CBA59458-F5A9-44E8-8CCA-49F2DD59771C Q21559661-EFC39E1F-2FD5-4EF7-95DA-78ACE9C905D1 Q21999477-B68C7F87-CCC4-41EC-986D-C87C2E6C4454 Q22122065-31F590B2-0078-4574-A673-D0B0E514F7A4 Q22242276-C154809B-DB80-422C-966C-31E2BD36615E Q24289006-8AAE56FB-878A-4541-9F2A-EEDFC18E6321 Q24296484-4D73A529-09AA-4923-8970-4AF2B3D24814 Q24299326-B21C90D8-920A-44BD-A623-D4C1AB340135 Q24301472-419FE24A-637B-4736-AFB8-B4A9DC70A921 Q24308021-6ABB1F62-B7A6-411F-B9BC-A590CBCFFE6D Q24317107-01F03A9E-DD54-4980-B7CC-49669503A441 Q24338226-C9D1E6CD-E5BB-4011-B4F8-38963FAF7DD0 Q24595911-16046EC6-CE1F-42B0-A62C-28A9D1B10193 Q24596715-0479278D-015E-4A75-9070-8E1370EC2DD5 Q24604831-08A0D01D-A5E1-40B3-BCCE-140428BE36D7 Q24606808-898A2CCA-E834-4B5A-86F0-CD6B8446D170 Q24613508-556C5A7D-36E7-4DE2-B954-F333A1E3B1C8 Q24621116-4568E515-6976-4F21-AAFE-3FFC5704A7ED Q24658633-382F9560-0357-471A-A1B3-F560FE0FDCAE Q26738985-E9DD02D9-B0D8-47ED-9322-7AD350FA99F8 Q26738987-24306122-2DAB-4EB7-9A0B-59131D4A99AC Q26739836-75A14605-00CF-4F14-8F53-22DC0421B245 Q26740184-D0E23153-53C9-4E30-9733-EF1D044E41F8 Q26741279-7E87C77B-DE7A-4139-B5F9-6DCD92B5FC5A Q26743510-CABC47D0-522F-468D-9642-F13D066B205F Q26745657-D7DFC375-F34C-4DFE-91E8-EE313B257943 Q26746952-8734EB90-8928-480F-8246-82B529BD03CC Q26747279-C0F7FCC6-6EA8-497C-92B6-F1353ABA3D10 Q26747729-68FC0139-BA1E-4C6A-8DBC-F14B246AB074 Q26748546-46AB55DE-BB17-4B87-9134-D162110D04BD Q26749272-6C33307B-D4F1-420F-8BDD-8424B26CD75D Q26750380-08B9C414-9D37-46CC-BC2B-FFFAF3223DBA Q26752780-F08B2C33-F75D-40ED-9A4C-3720250B99AC Q26766093-10EF0542-1CB6-4EA7-BCA2-C571522F51F7 Q26766266-D9E3A2DF-C4FD-47ED-BB72-B8D668D102B8 Q26766271-0FFE3FE1-06E3-417C-80AA-EEEA5C1F8D0D Q26766390-D4368B56-8AF2-41CD-9953-E2320F129A59 Q26768290-9867F7D2-861A-4C35-BEEC-23034792CEE8 Q26771394-FD610731-0FF2-4BC9-B862-B77448DEC820

P2860

Comprehensive molecular portraits of human breast tumours

http://www.wikidata.org/entity/Q24630844

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Comprehensive molecular portraits of human breast tumours

@ast

Comprehensive molecular portraits of human breast tumours

@en

Comprehensive molecular portraits of human breast tumours

@nl

type

label

Comprehensive molecular portraits of human breast tumours

@ast

Comprehensive molecular portraits of human breast tumours

@en

Comprehensive molecular portraits of human breast tumours

@nl

prefLabel

Comprehensive molecular portraits of human breast tumours

@ast

Comprehensive molecular portraits of human breast tumours

@en

Comprehensive molecular portraits of human breast tumours

@nl

P1433

Q24630844-56807A8A-0387-4959-B713-F665763AC222

P1476

Q24630844-4A000F07-64EB-4A93-A4A2-5E77F326DD3C

P2860

Q24630844-0B24E54D-C4E3-4D2B-A4A5-CC1231CA2167

Q24630844-0DECF499-6519-44F5-806C-CB1A8B782535

Q24630844-1C1C4E9E-7750-4E04-96E6-296BA16A242C

Q24630844-258FC30F-8AD6-43D8-AA48-78A6C0594D2C

Q24630844-2B7F9EB0-6633-44A0-A65E-ECC8BCBA76CD

Q24630844-2F300DCE-A232-4A2C-8D3A-1E1BA64EB0C3

Q24630844-36110D6D-3862-4865-AF7D-FDA015802AF5

Q24630844-3646FF27-9A3C-4C47-9965-1DA980E3822D

Q24630844-3939E4A8-E6E1-400E-9026-F8039AA522B2

Q24630844-3F956FBE-0FBC-4B71-A6FF-1F37296F532C

P2888

Q24630844-314CAB99-7EED-47F3-B8BB-24D047F4207F

P304

Q24630844-48C2B070-6483-46A3-90C1-E16583776571

P31

Q24630844-BF58E6C6-18A4-4BCE-BB9A-849FA0E9CD8A

P3181

Q24630844-A0F4576A-395E-4BA5-B9F0-8D96B267F096

P356

Q24630844-35F39199-6DE9-462F-879E-0659F610C822

P407

Q24630844-25B89F0C-2F2B-4F44-9F98-7C04BD01C78C

P433

Q24630844-25FCECF2-E85B-4BCC-B34D-738D21D0F891

P478

Q24630844-37BBB45C-5B53-42BA-B22D-C7A69D24FD17

P577

Q24630844-90884305-7793-4329-A712-3E193A44C41C

P5875

Q24630844-1EF3D8EE-52ED-4854-B8AD-A0E32EEF7DB8

P6179

Q24630844-B0F61862-2E02-4245-A086-E353452999B4

P698

Q24630844-94E3407E-1CA4-49A8-92ED-2B181EF41194

P921

Q24630844-5ba9aa1e-4049-ecbc-bb52-7baf1d1664ce

P932

Q24630844-C32BAB97-0054-4903-9DD7-B0225B792121

P3181

P356

P1433

P1476

Comprehensive molecular portraits of human breast tumours

@en

P2860

Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family

Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome

Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing

miRBase: integrating microRNA annotation and deep-sequencing data

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Somatic mutations affect key pathways in lung adenocarcinoma

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

Integrated genomic analyses of ovarian carcinoma

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

P2888

P304

61-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

8794

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE11412

http://www.w3.org/2001/XMLSchema#string

P407

P433

7418

http://www.w3.org/2001/XMLSchema#string

P478

490

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232183933

http://www.w3.org/2001/XMLSchema#string

P6179

1024942368

http://www.w3.org/2001/XMLSchema#string

P698

23000897

http://www.w3.org/2001/XMLSchema#string

P921

P932

3465532

http://www.w3.org/2001/XMLSchema#string